Lygos
Lygos engineers yeast to convert sugar into high-value industrial…
Synthetic Biology
Climate
Biotechnology
About
Founded in 2010, Lygos is providing biotechnology solutions for today’s renewable chemical challenges. They engineer microbes to convert sugars into high-value, industrial chemicals, targeting compounds where biological production is cost-advantaged over petrochemical production.
Build your own investing agent
GPAgent keeps YC listings public and neutral. Fund-specific scoring, notes, and workflow state live in each customer workspace.
Join the GPAgent waitlistFounders (1)
Eric Steen
Founder/CSO
Details
Status
Active
Stage
Growth
Team Size
55
Regions
United States of America, America / Canada